Cargando…

Effects of renin–angiotensin inhibitors on renal function and the clinical course in patients with decompensated cirrhosis

Patients with decompensated cirrhosis are at risk of developing acute kidney injury (AKI). Studies have suggested that inhibition of the Renin-Angiotensin System (RAS) has certain nephro- and hepatoprotective effects in patients with compensated liver disease. This study aimed to investigate the cli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tergast, Tammo L., Griemsmann, Marie, Wedemeyer, Heiner, Cornberg, Markus, Maasoumy, Benjamin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576780/ https://www.ncbi.nlm.nih.gov/pubmed/37838780 http://dx.doi.org/10.1038/s41598-023-44299-w

Ejemplares similares

Nosocomial infections in female compared with male patients with decompensated liver cirrhosis
por: Griemsmann, Marie, et al.
Publicado: (2022)

Antimicrobial resistance in patients with decompensated liver cirrhosis and bacterial infections in a tertiary center in Northern Germany
por: Hillert, Annika, et al.
Publicado: (2021)

Sustained impact of nosocomial-acquired spontaneous bacterial peritonitis in different stages of decompensated liver cirrhosis
por: Kimmann, Markus, et al.
Publicado: (2019)

Association Between Type 2 Diabetes Mellitus, HbA1c and the Risk for Spontaneous Bacterial Peritonitis in Patients with Decompensated Liver Cirrhosis and Ascites
por: Tergast, Tammo L., et al.
Publicado: (2018)

Daily Low-Volume Paracentesis and Clinical Complications in Patients With Refractory Ascites
por: Tergast, Tammo L., et al.
Publicado: (2023)

Frequency, characteristics and impact of multiple consecutive nosocomial infections in patients with decompensated liver cirrhosis and ascites
por: Schultalbers, Marie, et al.
Publicado: (2020)

Safety and feasibility of transjugular intrahepatic portosystemic shunt in elderly patients with liver cirrhosis and refractory ascites
por: Stockhoff, Lena, et al.
Publicado: (2020)

Diastolic dysfunction is associated with cardiac decompensation after transjugular intrahepatic portosystemic shunt in patients with liver cirrhosis
por: Schneider, Hannah, et al.
Publicado: (2023)

Low Serum Cholinesterase Identifies Patients With Worse Outcome and Increased Mortality After TIPS
por: Stockhoff, Lena, et al.
Publicado: (2021)

Reaching the Unreachable: Strategies for HCV Eradication in Patients With Refractory Opioid Addiction—A Real-world Experience
por: Sandmann, Lisa, et al.
Publicado: (2021)

Chronotherapy with a Renin-angiotensin System Inhibitor Ameliorates Renal Damage by Suppressing Intrarenal Renin-angiotensin System Activation
por: Aoki, Taro, et al.
Publicado: (2020)

HBcrAg Levels Are Associated With Virological Response to Treatment With Interferon in Patients With Hepatitis Delta
por: Sandmann, Lisa, et al.
Publicado: (2021)

Impact of HBsAg and HBcrAg levels on phenotype and function of HBV-specific T cells in patients with chronic hepatitis B virus infection
por: Aliabadi, Elmira, et al.
Publicado: (2022)

Implications of renin‐angiotensin‐system blocker discontinuation in acute decompensated heart failure with systolic dysfunction
por: Darden, Douglas, et al.
Publicado: (2019)

Performance of Two HCV RNA Assays during Protease Inhibitor-Based Triple Therapy in Patients with Advanced Liver Fibrosis and Cirrhosis
por: Maasoumy, Benjamin, et al.
Publicado: (2014)

Renin-Angiotensin-Aldosterone Inhibitors and COVID-19
por: Benenson, Irina, et al.
Publicado: (2020)

Decompensated Cirrhosis after Renal Transplantation: A Case Report
por: Patel, Vinay, et al.
Publicado: (2011)

Renin angiotensin aldosterone system (RAAS) inhibitors in the prevention of early renal disease in diabetes
por: Gnudi, Luigi, et al.
Publicado: (2010)

Effects of Sodium Glucose Cotransporter 2 Inhibitor on Renal Renin-Angiotensin-Aldsoterone System
por: Takeda, Yoshiyu, et al.
Publicado: (2021)

Renal Modulation: The Renin-Angiotensin-Aldosterone System (RAAS)
por: Natarajan, Aruna, et al.
Publicado: (2008)

Eligibility and Safety of Triple Therapy for Hepatitis C: Lessons Learned from the First Experience in a Real World Setting
por: Maasoumy, Benjamin, et al.
Publicado: (2013)

Improving Survival in Decompensated Cirrhosis
por: Mukerji, Amar Nath, et al.
Publicado: (2012)

Management options in decompensated cirrhosis
por: Shah, Neeral L, et al.
Publicado: (2015)

COVID-19 in decompensated cirrhosis
por: Rela, Mohamed, et al.
Publicado: (2020)

Decompensation of Cirrhosis: An Unusual Cause
por: Rudra, Omkar S, et al.
Publicado: (2022)

Inhibitors of the Renin–Angiotensin–Aldosterone System and Covid-19
por: Jarcho, John A., et al.
Publicado: (2020)

Hypothesis for renin-angiotensin inhibitor mitigation of COVID-19
por: Sackin, Henry
Publicado: (2021)

Renin–Angiotensin–Aldosterone Inhibitors and COVID-19 Infection
por: Tsampasian, Vasiliki, et al.
Publicado: (2022)

Patterns of acute decompensation in hospitalized patients with cirrhosis and course of acute‐on‐chronic liver failure
por: Balcar, Lorenz, et al.
Publicado: (2021)

What’s new in the renin-angiotensin system?: What’s new in the renin-angiotensin system?
por: Smith, A. I., et al.
Publicado: (2004)

Renin angiotensin system deregulation as renal cancer risk factor
por: Sobczuk, Paweł, et al.
Publicado: (2017)

Effect of renal denervation on catecholamines and the renin–angiotensin–aldosterone system
por: Feyz, Lida, et al.
Publicado: (2020)

Renal medullary (pro)renin receptor contributes to angiotensin II-induced hypertension in rats via activation of the local renin–angiotensin system
por: Wang, Fei, et al.
Publicado: (2015)

GENETIC INFLUENCE ON THE RENIN-ANGIOTENSIN SYSTEM : EVIDENCE FOR A RENIN INHIBITOR IN HYPERTENSION-PRONE RATS
por: Iwai, Junichi, et al.
Publicado: (1970)

Renin-Angiotensin System and Cardiovascular Functions
por: Wu, Chia-Hua, et al.
Publicado: (2018)

Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update
por: Shukla, Ashwin Kumar, et al.
Publicado: (2021)

Improving Survival in Patients with Decompensated Cirrhosis
por: Amarapurkar, Deepak, et al.
Publicado: (2011)

Safety of the neprilysin/renin-angiotensin system inhibitor LCZ696
por: Li, Bo, et al.
Publicado: (2017)

Therapeutic effect of renin angiotensin system inhibitors on liver fibrosis
por: Zhu, Qianqian, et al.
Publicado: (2016)

Renin-Angiotensin System Inhibitors in COVID-19: Current Concepts
por: Mahajan, Kunal, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0cva4crjstd23b30ieo3037v6u